Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAPR Capricor Therapeutics Inc

已收盘 06-10 16:00:00 EDT

25.33

-0.68

-2.61%

盘后25.64

+0.31+1.22%

19:26 EDT

最高26.42	最低25.01	成交量148.42万
今开25.98	昨收26.01	日振幅5.42%
总市值14.65亿	流通市值12.26亿	总股本5,784万
成交额3,778万	换手率3.07%	流通股本4,842万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":25.33,"timestamp":1781121600000,"preClose":26.01,"halted":0,"volume":1484247,"hourTrading":{"tag":"盘后","latestPrice":25.64,"preClose":25.33,"latestTime":"19:26 EDT","volume":11462,"amount":289800.2852,"timestamp":1781133994834,"change":0.31,"changeRate":0.012238,"amplitude":0.019739},"delay":0,"changeRate":-0.02614379084967333,"floatShares":48418500,"shares":57840102,"eps":-2.32142,"marketStatus":"已收盘","change":-0.68,"latestTime":"06-10 16:00:00 EDT","open":25.98,"high":26.42,"low":25.01,"amount":37780725.186831,"amplitude":0.05421,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.32142,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781164800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":26.01,"preHourTrading":{"tag":"盘前","latestPrice":25.97,"preClose":26.01,"latestTime":"09:29 EDT","volume":1599,"amount":41536.361139,"timestamp":1781098199999,"change":-0.04,"changeRate":-0.001538,"amplitude":0.00346},"postHourTrading":{"tag":"盘后","latestPrice":25.64,"preClose":25.33,"latestTime":"19:26 EDT","volume":11462,"amount":289800.2852,"timestamp":1781133994834,"change":0.31,"changeRate":0.012238,"amplitude":0.019739},"volumeRatio":2.15456,"impliedVol":0.4311,"impliedVolPercentile":0.012},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"1101669758","title":"Capricor Therapeutics：可用现金、现金等价物及有价证券足以支撑其运营至2027年第四季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1101669758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101669758?lang=zh_cn&edition=full","pubTime":"2026-05-13 04:18","pubTimestamp":1778617095,"startTime":"0","endTime":"0","summary":"生物技术公司Capricor Therapeutics Inc. 宣布，其当前持有的可用现金、现金等价物及市场流通有价证券，预计足以覆盖公司运营支出及资本需求，直至2027年第四季度。这一资金状况为公司推进其核心研发管线提供了坚实的财务保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137341631","title":"Capricor Therapeutics指控Ns Pharma未做好Deramiocel上市准备并违反协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1137341631","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137341631?lang=zh_cn&edition=full","pubTime":"2026-05-08 04:44","pubTimestamp":1778186647,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，生物制药公司Capricor Therapeutics已正式指控其合作伙伴Ns Pharma未能充分准备Deramiocel疗法的商业化上市工作，并涉嫌违反双方既定的合作协议。该文件显示，Capricor方面认为Ns Pharma在推进细胞疗法Deramiocel的上市筹备过程中存在重大疏漏，未能履行协议约定的商业推广责任。此次纠纷可能对Deramiocel这一备受关注的创新疗法的市场推进计划产生直接影响。业界正密切关注这一商业纠纷的后续发展，特别是其对Deramiocel疗法上市时间表的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179000631","title":"Capricor Therapeutics将于5月12日公布2026年第一季度财报并更新企业动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1179000631","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179000631?lang=zh_cn&edition=full","pubTime":"2026-05-05 04:06","pubTimestamp":1777925181,"startTime":"0","endTime":"0","summary":"生物制药公司Capricor Therapeutics Inc（股票代码：CAPR）宣布，将于2026年5月12日发布第一季度财务业绩报告。届时，公司管理层将同步披露最新业务进展与战略规划。\n此次财报发布将涵盖公司核心产品线的研发进度、商业化布局以及财务状况等关键信息。投资者可通过电话会议或网络直播参与业绩说明会，与管理层直接交流。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518279724","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.15%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518279724?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Capricor Therapeutics, Inc.股票出现波动，股价急速下跌5.15%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516378816","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516378816?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:52","pubTimestamp":1741013572,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时52分，Capricor Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为687.54%、115.08%、86.65%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、40.78%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514967857","title":"Capricor Therapeutics, Inc.盘中异动 快速下跌5.00%报15.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514967857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514967857?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:52","pubTimestamp":1740585161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时52分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5442.90%、206.70%、195.43%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778370","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.20%报14.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778370?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:56","pubTimestamp":1740409003,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时56分，Capricor Therapeutics, Inc.股票出现异动，股价大幅下跌5.20%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为142.31%、59.62%、25.08%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256449890fc11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256449890fc11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512111193","title":"Capricor Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报15.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512111193?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:17","pubTimestamp":1739902679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时17分，Capricor Therapeutics, Inc.股票出现波动，股价快速下挫5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为667.76%、198.57%、164.56%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021759988a21c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021759988a21c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509323572","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509323572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509323572?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:16","pubTimestamp":1738772201,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时16分，Capricor Therapeutics, Inc.股票出现异动，股价快速下挫5.11%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4256.80%、1754.28%、1304.65%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600164196191b62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600164196191b62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507717671","title":"Capricor Therapeutics, Inc.盘中异动 下午盘快速上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507717671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507717671?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:36","pubTimestamp":1738262178,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时36分，Capricor Therapeutics, Inc.股票出现波动，股价大幅上涨5.47%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Nutriband Inc C/Wts 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1768.86%、288.24%、236.24%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013102361996145887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013102361996145887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503284836","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503284836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503284836?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:02","pubTimestamp":1736953340,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时02分，Capricor Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Exicure, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为197.30%、121.96%、72.63%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、60.10%、54.40%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152302209867440d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152302209867440d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493579019","title":"Capricor Therapeutics盘中异动 快速上涨5.05%报13.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493579019","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493579019?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:24","pubTimestamp":1734985493,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时21分，Capricor Therapeutics, Inc.股票出现波动，股价急速上涨5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224042454ab8ed44a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224042454ab8ed44a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492612717","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492612717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492612717?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:11","pubTimestamp":1734369082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时11分，Capricor Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491051843","title":"Capricor Therapeutics, Inc.盘中异动 快速跳水5.09%报13.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491051843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491051843?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:34","pubTimestamp":1734111268,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时34分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下跌5.09%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489379239","title":"Capricor Therapeutics, Inc.盘中异动 快速上涨5.23%报15.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489379239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489379239?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:34","pubTimestamp":1733495662,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时34分，Capricor Therapeutics, Inc.股票出现异动，股价急速上涨5.23%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223422a1d970af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223422a1d970af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120740922","title":"异动解读 | Capricor Therapeutics股价 盘中大涨22.44% 罕见病新药临床前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1120740922","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120740922?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:08","pubTimestamp":1733411329,"startTime":"0","endTime":"0","summary":"生物技术企业Capricor Therapeutics Inc 今日盘中股价大涨22.44%,引发市场关注。分析人士指出,该股价大涨或与公司正在研发的针对罕见疾病的新药临床前景被看好有关。Capricor目前主要产品CAP-1002和deramiocel正处于临床开发阶段,拟用于治疗杜氏肌营养不良症。总体而言,投资者预期Capricor Therapeutics在研药物和创新技术平台未来可能带来较大的回报和增长空间,因而对其长期发展前景抱有信心,推动了该股价格的大幅上涨。但具体引发这一涨幅的消息还有待进一步跟踪和了解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Capricor Therapeutics股价 盘中大涨22.44% 罕见病新药临床前景看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489457290","title":"Capricor Therapeutics, Inc.股价飙升16.12% 市值涨1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457290?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:32","pubTimestamp":1733409126,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时32分，Capricor Therapeutics, Inc.股票出现波动，股价大幅拉升16.12%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1757.73%、240.08%、206.65%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Biomx Inc.，振幅分别为36.44%、18.25%、10.98%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223206ab5ffd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223206ab5ffd80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488750945","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488750945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488750945?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:34","pubTimestamp":1733236461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时34分，Capricor Therapeutics, Inc.股票出现波动，股价大幅上涨5.50%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为129.84%、64.69%、54.19%，振幅较大的相关个股有Coherus Biosciences, Inc.、万春医药、Cabaletta Bio, Inc.，振幅分别为24.09%、13.02%、12.35%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223421a269971e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223421a269971e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488988370","title":"Capricor Therapeutics, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488988370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488988370?lang=zh_cn&edition=full","pubTime":"2024-12-03 03:56","pubTimestamp":1733169360,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日03时56分，Capricor Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2891.44%、2675.09%、663.42%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303560198e4f5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303560198e4f5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486488410","title":"Capricor Therapeutics, Inc.盘中异动 急速上涨5.18%报19.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486488410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486488410?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:52","pubTimestamp":1732643543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时52分，Capricor Therapeutics, Inc.股票出现异动，股价急速拉升5.18%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127015223971a8b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127015223971a8b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":-0.0486},{"period":"1month","weight":-0.1438},{"period":"3month","weight":-0.2252},{"period":"6month","weight":-0.043},{"period":"1year","weight":0.9439},{"period":"ytd","weight":-0.0988}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.于2005年8月在特拉华州注册成立。该公司是一家专注于开发细胞和外泌体疗法的生物技术公司，主要用于治疗杜氏肌营养不良症。其主要候选药物Deramiocel是一种细胞疗法，目前正在接受FDA审查，用于治疗DMD的心脏和骨骼肌并发症。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.12654},{"month":2,"riseRate":0.545455,"avgChangeRate":0.012535},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.010585},{"month":4,"riseRate":0.5,"avgChangeRate":0.425005},{"month":5,"riseRate":0.25,"avgChangeRate":-0.148881},{"month":6,"riseRate":0.583333,"avgChangeRate":0.021243},{"month":7,"riseRate":0.363636,"avgChangeRate":0.07472},{"month":8,"riseRate":0.545455,"avgChangeRate":0.008533},{"month":9,"riseRate":0.454545,"avgChangeRate":0.348894},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.099314},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.0945},{"month":12,"riseRate":0.181818,"avgChangeRate":0.280594}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}